Zachary Frehlick

Zachary Frehlick is an innovative inventor based in Vancouver, Canada. He has made significant contributions to the field of medical technology, particularly in the area of evoked potential measurement. His work focuses on enhancing the accuracy and efficiency of neurological assessments through advanced systems and methods.

Latest Patents

Zachary Frehlick holds a patent for a "System and method for automatic evoked potential measurement." This invention is designed to automatically determine the amplitude and latency of one or more evoked potential (EP) or event-related potential (ERP) from electroencephalography (EEG) data. The system separates EEG data from scans into epochs that contain the desired EP or ERP waveforms. It averages epochs corresponding to the same type of EP or ERP, such as N100, P300, and N400, automatically. The averaged epochs are then filtered in the time-frequency domain using a selected filtering mask associated with the type of EP or ERP. Finally, the system automatically identifies a corresponding peak from the filtered epoch, measuring the amplitude and latency.

Career Highlights

Zachary Frehlick is currently employed at Health Tech Connex Inc., where he continues to develop innovative solutions in health technology. His work is pivotal in advancing the capabilities of EEG analysis and improving patient outcomes in neurological assessments.

Collaborations

Zachary collaborates with talented professionals in his field, including Ryan Clarke, Newell D'Arcy, and Fabio Bollinger. These collaborations enhance the development and implementation of his innovative technologies.

Conclusion

Zachary Frehlick's contributions to the field of evoked potential measurement demonstrate his commitment to advancing medical technology. His innovative patent reflects a significant step forward in the automatic analysis of EEG data, which has the potential to improve diagnostic processes in neurology.

Profile summary based on public USPTO records.